Sanofi

Projected market growth driven by expanded treatment options, novel therapies, and rising diagnosed prevalence across major global…

ATMF report recommends practical solutions whereby companies can bring about the fundamental shift that is required to scale up…

Dr Reddy’s to promote and distribute nirsevimab-based drug Beyfortus for RSV in newborns and infants

FDA clears Dupixent for chronic spontaneous urticaria in patients aged 12 and above, expanding its use in immune-related skin…

Sanofi is planning a phase 1/2 randomised, clinical study designed to evaluate the immunogenicity and safety of the chlamydia…

Consolidation has emerged as a major trend as the pharma industry seeks new avenues of growth and looks to expand its existing…

Cialis (tadalafil) in the US is currently only available with a prescription. Cialis is a tablet taken to treat erectile…

GlobalData’s latest report reveals that market growth will primarily be driven by the uptake of new monoclonal antibodies (mAbs),…

With the growth in AD, investment opportunities seem to be exciting, and pharmaceutical companies could invest in the R&D of…

Plans €400 million investment by 2030, with €100 million by 2025; expanded center will host up to 2600 employees